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aa   Amino acid 
APC    Antigen presenting cells 
ATP   Adenosine triphosphate 
CHSE-214        Chinook salmon embryo cells 
CISH   Cytokine-inducible SH2- containing protein 
CpG   Cytosine-phosphate-guanine 
DBD   DNA-binding domain 
DNA   Deoxyribonucleic acid 
FERM  Four point, ezrin, radixin, moesin 
GAS   Gamma interferon activation site 
HK   Head kidney 
IFN   Interferon 
IFNAR  Interferon α/β receptor 
IFNGR  Interferon γ receptor 
IL28R   Interleukin 28 receptor 
IL-10R2  Interleukin 10 receptor 2 
IPNV   Infectious pancreatic necrosis virus 
IRF   Interferon regulatory factor 
ISAV   Infectious salmon anemia virus 
ISG   Interferon stimulated gene 
ISGF3  Interferon stimulated gene factor 3 
ISRE   Interferon stimulated response element 
JAK   Janus kinase 
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JH  Janus homology 
kDa  Kilo Dalton 
KIR  Kinase inhibitor region 
LPS   Lipopolysaccharide 
mRNA  messenger RNA 
Mx   Myxovirus resistance 
MyD88  Myeloid differentiation primary response gene 88 
NES   Nuclear export signal 
ND   N-terminal domain 
NK  Natural killer cells 
NLR  Nod like receptor 
NLS   Nuclear localization signal 
PAMP  pathogen-associated molecular pattern 
PCR   Polymerase chain reaction 
pDC   Plasmacytoid dendrittic cell 
PIAS   Protein inhibitor of activated STAT1 
Poly I:C  Polyinosinic polycytidylic acid 
PRR   Pattern recognition receptor 
qPCR   quantitative PCR 
PTP   protein tyrosine phosphatases 
RIG-I   Retinoic acid inducible gene I 
RLR   RIG-I- like receptors 
RNA   Ribonucleic acid 
SH2   Src homology 2 
SHP   SH2-containing Protein Tyrosine Phosphatase 
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PTP   Protein Tyrosine Phosphatase 
SOCS   Supressor of cytokine signaling 
STAT   Signal transducers and activators of transcription 
TAD   Transcriptional activation domain 
TLR   Toll-like receptor 
TNF   Tumor necrosis factor 
TO   Atlantic salmon head kidney cell-line 






















In mammals the JAK-STAT pathway plays a significant role in mediating the biological activities 
of both type I and type II IFN, where JAKs are receptor associated kinases and STATs the 
transcription factors they activate. At the start of this project the knowledge of the JAK-STAT 
pathway in fish in general was scarce and there were few reports describing the function of any 
JAK-STAT family member in the Atlantic salmon. There was also very limited knowledge about 
molecules involved in regulation of this signaling pathway in fish. In this project period we have 
cloned and / or initiated studies of the functional activity of the transcription factors STAT1, 
STAT2 and IRF9 and also the TYK2 kinase, as well as several members of the suppressors of 
cytokine signaling (SOCS) family derived from salmon.  
In paper I two full length and two truncated isoforms of salmon Tyk2 were identified. The full 
length Tyk2 had the same domain structure as its mammalian counterpart and like its mammalian 
homolog salmon TYK2 was shown to be autophosporylated on tyrosine residues when 
overexpressed in salmon cell lines, while a mutation in the ATP binding site abolished this 
activity. This suggests that the phosphorylation of salmon TYK2 is a result of auto-
phosphorylation and not caused by the activity of another kinase. Our experiments showed that 
cells overexpressing TYK2 produced higher levels of Mx transcripts and Mx-promoter activation 
upon IFN-treatment then the controls overexpressing empty vector. These results suggest that 
TYK2 in salmon has a role in mediating IFN-signaling. 
In paper II salmon IRF9 and two STAT2 isoforms (STAT2a and STAT2b) were cloned and 
further characterized and the identified molecules showed functional conservation to their 
mammalian counterparts. STAT2a and STAT2b were tyrosine phosphorylated as result of both 
type I and type II IFN stimulation and they translocated to the nucleus when co-expressed with 
STAT1a or IRF9. STAT1a did interact with STAT2a and STAT2b, and all three molecules did 
interact with IRF9 as well as Tyk2. 
Regulation of innate immune responses, including IFN-induction, is critical since excessive 
inflammatory reaction can be deleterious. The SOCS proteins are involved in the negative 
regulation of the JAK/STAT pathway.  Although, SOCS proteins have been studied extensively 
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in mammals they are still poorly characterized in lower vertebrates, including fish. In the third 
paper in this thesis we have cloned and characterized 3 Atlantic salmon SOCS-family members, 
SOCS1, SOCS2 and CISH, which all showed high conservation to their mammalian homologs.  
In the basal state all three SOCS-molecules were expressed at low levels in organs and cells. 
However, upon stimulation by IFNs or TLR-ligands their expression, and SOCS1 in particular, 
were rapidly induced, showing that their induction occur through ligands associated with both 
JAK/STAT and TLR-signaling. The most exciting finding regarding the SOCS-protein was that 
IFN-mediated antiviral responses in fish. 
In conclusion, this work contributes to understanding of JAK/STAT signaling in Atlantic salmon 
and shows that this signaling pathway is conserved between Atlantic salmon and mammals, 
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Teleost fish species constitute almost half of the vertebrate species in existence today and 
different members of teleost fish are farmed in greater numbers than ever before. This is a 
stressful process which also renders fish susceptible to different viral infections. In addition to the 
negative impact on the fish welfare, infectious outbreaks cause major economic losses which the 
farming industry has to deal with.  The JAK / STAT signaling is a conserved signaling pathway 
in the animals. In higher vertebrates detection of virus leads to expression of interferons (IFNs) 
which activates JAK/STAT signaling pathway. Activation of JAK/STAT signaling leads to 
expression of many ISGs that induce an antiviral state in the organism. This fact inevitably makes 
this signaling pathway a major target for immune evasion strategies used by viruses. Thus a 
detailed understanding of molecules involved in the JAK/STAT signaling is an important pre-
requisite in the understanding of viruses immune evasion strategies and a necessary step in 




The immune system of higher vertebrate is divided into an innate and an adaptive branch. The 
innate immune system is the first line of defense against the invading microorganisms and 
viruses, and is immediately available to combat threats.  It responds to common structures shared 
by groups of pathogens, these common structures are called pathogen associated molecular 
patterns (PAMPs) and they are detected through pathogen recognition receptors (PRRs). The 
different PRRs are specific for different components of microbes and viruses like LPS, proteins, 
peptidoglycans, DNA and /or RNA and they are constitutively expressed in effector cells of the 
innate immune system including professional antigen presenting cells (APC) and epithelial cells 
(Medzhitov and Janeway, 1997).  
Several families of PRRs are recognized including Toll like receptors (TLRs), RIG-I- like 
receptors (RLRs), NOD-like receptor (NLRs)  and cytosolic DNA receptors, reviewed in 
(Beutler, 2009, O'Neill et al., 2013, Loo and Gale, 2011, Barber, 2011, Kvarnhammar et al., 
10 
 
2011). While TLRs are expressed either on the cell surface or on lysosomal or endosomal 
membranes, the RLRs and the NLRs are found in the cytoplasm. Upon binding to their PAMPs, 
most PRRs activate different signaling pathways that regulate the activation of different 
transcription factors resulting in the secretion of many cytokines and chemokines from innate 
immune cells. 
 
Cytokines and the immune system 
 
Cytokines are small signaling proteins / peptides that are secreted by cells which mediate and 
regulate immunity, inflammation and hematopoiesis. They exert their function through autocrine 
(binding to the receptors on the cells that secrete them) and/or paracrine (binding to the receptors 
on secreting cells and those in their proximity) and/or endocrine (entering circulation and 
effecting cells in other parts of the body) activity.  
During viral infections, some of the most important defense molecules produced are IFNs and 
they were also the first cytokine group identified. IFN was discovered as a secretory factor when 
Isaacs and Lindenmann were studying an already established principle of virus interference 
(Isaacs and Lindenmann, 1957). IFNs are cytokines that “interfere” with virus replication; they 
are produced and secreted by the infected cells of the organism in response to virus infection and 
act in autocrine and paracrine manner (Gautier et al., 2005, Gao et al., 1998, Curtsinger et al., 
2012). Expression of IFNs leads to expression of many IFN stimulated genes (ISGs), among 
them many antiviral proteins. 
In human as well as in a number of other mammalian species there are 3 classes of IFNs 
identified; type I, type II and type III IFNs, and the 3 different classes are shown to interact with 
different receptors and to trigger specific signaling pathways. Type I IFN, which in mammals 
include IFNα`s and IFNβ, are most likely produced by almost all tissues and cell types when they 
are exposed to appropriate stimuli (Pestka, 2007, Pestka et al., 2004). Type II IFN consists of 
IFNγ and is predominantly produced by T-cells and NK-cells (Schroder et al., 2004). The main 
function of IFNγ is probably not being an antiviral cytokine, but rather acting as a regulatory 
cytokine in both innate and adaptive immunity. Type III IFN include IFNλ`s (Sheppard et al., 
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2003). While type I and type II IFN receptors are expressed by most cells, expression of receptors 
for type III IFN are highly restricted (Sommereyns et al., 2008, Pott et al., 2011). Both type I, II 
and III IFN demonstrate antiviral activity (Osterlund et al., 2005, Schroder et al., 2004, Kotenko 
et al., 2003), however, its type I IFN that is involved in the early response to viral infection. 
Several members of type I IFN with high structural homology are identified in mammals, 13 
IFNα (IFNα-1, 2, 4, 5, 6, 7, 8, 10, 13, 14, 16, 17, 21)   and one IFNβ and also IFN-ε, κ,τ and more 
(Pestka et al., 2004). Although most cell types do secrete type I IFN, there are several types of 
cells in different tissues that express type I IFN in response to various viral infections. 
 
Cells producing type I IFNs 
 
One of the main type I IFN producing cell type is plasmacytoid dendritic cells (pDC`s) reviewed 
in (McKenna et al., 2005, Reizis et al., 2011). These cells are resistant to viral replication since 
they constitutively express molecules like IFN regulatory factor (IRF) 7 that are important for 
type I IFN expression (Izaguirre et al., 2003). pDC`s are activated through the MyD88 signaling 
pathway. This occurs when viruses enter endosomal compartments through endocytosis or 
autophagy and their RNA and / or DNA is detected by the endosomal receptors TLR7 and 9, 
respectively (Lund et al., 2004, Krug et al., 2004, Lund et al., 2003). pDC`s are an important 
source of type I IFN in systemic infections (Swiecki et al., 2013) and in defense against 
infections in skin (Bond et al., 2012), but their impact is limited in time and capacity. Some of the 
other cell types involved in type I IFN secretion are epithelial and alveolar macrophages that are 
lining the airways and that are the main type I IFN producing cells during mucosal infections 
(Jewell et al., 2007, Kumagai et al., 2007). Epithelial cells produce type I IFN in gut and lungs in 
response to retrovirus and influenza virus, respectively, and neurons and astrocytes are an 
important source of type I IFN during brain infection (Delhaye et al., 2006, Kallfass et al., 2012).  
Many cytokines, including the IFNs transmit signals from cell-surface to the nucleus by 
activating members of the signal transducers and activators (STAT) family. The STAT proteins 
are activated by tyrosine phosphorylation that alters their confirmation to allow specific binding 
to other proteins and nuclear localization (Kiu and Nicholson, 2012). Type I IFN receptors 
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(IFNAR1 and IFNAR2) and type III IFN receptors (IL28R / IL-10R2) are associated with Janus 
Kinase (JAK) 1 and Tyrosine kinase 2 (Tyk2), while type II IFN receptors (IFNGR1and 
IFNGR2) are associated with JAK1 and JAK2 (Pestka et al., 2004). 
 
JAK / STAT signaling pathway 
 
The Janus kinase/signal transducers and activators of transcription (JAK/STAT) pathway is one 
of the main pathways used to transduce signals from the cell membrane to the nucleus in animals 
from human to fruitfly. Principal compounds of JAK / STAT signaling pathway are JAKs and 
STATs, and in the case of type I IFN activated JAK / STAT signaling, also IRF9. The JAK / 
STAT signaling pathway is activated when ligands (i.e. different cytokines) bind to the 
extracellular domain of specific cellular receptors. This interaction leads to dimerization / 
multimerization of the receptor subunits, which bring JAKs – that are non-covalently associated 
with the intracellular domains of the receptors – in proximity of each other. This leads to auto- 
and transactivation of JAKs. Activated JAKs phosphorylate tyrosine residues on the receptors 
intracellular domains and on their substrates, the STATs. Phosphorylation of STATs leads to 
dimerization and translocation to the nucleus where they bind to specific DNA sequences and 
induce transcription of their target genes (Kiu and Nicholson, 2012, Stark and Darnell, 2012, 






FIGURE 1: JAK/STAT activation as result of type I and typ II IFN activity. 
Type I IFN interacts with IFNAR1 and IFNAR 2 on the target cells and activates JAK family members JAK1 and 
Tyk2. Activated JAKs phosphorylate STAT1 and STAT2, a process that leads to hetero dimerization of STATs. 
Dimerized STATs interact with IRF9 and form ISGF3 that binds to ISRE DNA sequence in the nucleus and activates 
expression of type I IFN sensitive genes (ISGs). Type II IFN interacts with IFNGR1 and IFNGR 2 subunits and 
activates JAK1 and JAK2 that phosphorylate STAT1. Phosphorylated STAT1 homo-dimerize and translocate to the 
nucleus and binds to GAS DNA sequence and activate expression of IFNγ sensitive genes. 
The figure is modified from (Platanias, 2005) 
 
JAK / STAT signaling is negatively regulated mainly by 3 classes of molecules; a) protein 
tyrosine phosphatases (PTPs) which inhibit the signaling by dephosphorylating the receptor and / 
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or activated JAKs and STATs, b) protein inhibitors of activated STATs (PIAS) which in some 
cases bind to dimerized STATs and inhibits their binding to DNA and c) suppressors of cytokine 
signaling (SOCS) that are expressed as result of JAK / STAT activation and bind to the JAKs and 
/ or the IFN receptors in order to inhibit the signaling (Rawlings et al., 2004). 
 
The Janus Kinases  
 
JAKs are a family of large protein tyrosine kinases with sizes ranging from 120 to 140 kDa. In 
mammals four members of this family are identified; JAK1, JAK2, JAK3 and Tyk2 (Firmbach-
Kraft et al., 1990, Wilks, 1989, Wilks, 1991, Harpur et al., 1992, Krolewski et al., 1990, 
Kawamura et al., 1994). Tyk2 was the first member of this family to be identified as an important 
molecule in formation of interferon stimulated gene factor 3 (ISGF3) as result of type I IFN 











JAKs have a characteristic structure that is conserved between mammal, avian, teleost and insect 
species and it is divided into 7 JAK homology domains (JH) named from the carboxyl end 
(Figure 2). JH1 on the proteins C-terminal end is a tyrosine kinase domain (Wilks et al., 1991); it 
has a similar structure to other protein tyrosine kinases and includes an ATP binding site and a 
catalytic site. Specific mutation at the ATP binding site inactivates kinase function, probably by 
inhibiting ATP binding (Gauzzi et al., 1996). On the tyrosine kinase domain there are two 
tyrosine residues that are phosphorylated when the kinase is activated. The pseudo kinase domain 
N   FERM   SH2   Pseudokinase   Tyrosine kinase 
JH7              JH6              JH5 JH4 JH3                          JH2                      JH1           




is located N-terminally to JH1, JH2 (Wilks et al., 1991) and shows all the hallmarks of protein 
tyrosine kinases but lacks kinase activity and it has been shown to act as a regulatory domain on 
tyrosine kinase. The kinase and the pseudo kinase domains seem to be evolutionary related 
(Wilks et al., 1991) . JH3 and JH4 constitute the Src homology 2 (SH2) like domain. And finally 
the JH6 – 7 domain which is named FERM (four point, ezrin, radixin, moesin) (Girault et al., 
1999). The FERM domain seems to interact with transmembrane proteins like cytokine receptors 
(Richter et al., 1998, Zhao et al., 1995, Frank et al., 1995, Velazquez et al., 1995) and in the case 
of Tyk2, this interaction is necessary to sustain IFNRA level (Gauzzi et al., 1997)  FERM also 
interacts with and positively regulates tyrosine kinase activity of JAKs. Inside the cell, JAKs are 
usually found in the cytosol, mostly associated with their receptors in the endosomes and at the 
plasma membrane (Yeh and Pellegrini, 1999). While JAK1, JAK2 and Tyk2 are constitutively 
expressed, JAK 3 is expressed only in hematopoietic cells and its expression is highly regulated 
through cell development and activation (Yeh and Pellegrini, 1999). 
  
The Signal Transducers and Activators of Transcription 
 
STATs are latent cytoplasmic transcription factors that are translocated to the nucleus upon 
activation and are found from mammals to insects and nematodes (Liongue and Ward, 2013). In 
mammals seven different STATs  have been identified and named STAT1, STAT2, STAT3, 
STAT4, STAT5a, STAT5b, and STAT6 (Leonard and O'Shea, 1998). STAT molecules have 
highly conserved domains and characteristic structure comprised of; N-terminal domain, coil-
coiled domain, DNA-binding domain (DBD), SH2 domain and transcription activation domain 






The N-terminal domain seems to be responsible for homo-dimerization of inactive STATs 
(Mertens et al., 2006, Mao et al., 2005) as well as their nuclear import, deactivation (Strehlow 
N C ND Coiled-coil DBD  SH2 TAD 
Figure 3: Domain like structure of STATs 
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and Schindler, 1998, Mertens et al., 2006) and their cooperative DNA-binding to tandem IFN-γ 
activation sequence (GAS) (Xu et al., 1996, Vinkemeier et al., 1996). The coiled – coil domain 
interacts with SH2 domain and facilitates its interaction with the receptor (Zhang et al., 2000). 
STAT coiled – coil is shown to interact with other proteins as well and in the case of STAT1 and 
STAT2 it is shown to bind other proteins like IRF9 (Horvath et al., 1996) and other regulatory 
proteins. The DBD binds to specific DNA sequences (Horvath et al., 1995, Ehret et al., 2001). 
Linker domain (LK) plays an important role for nuclear trans-location (Devaux et al., 2013) and 
in STAT1 it is essential for transcriptional activity of IFNγ (Yang et al., 1999, Yang et al., 2002) 
and in receptor recruitment and dimerization.The SH2 domain, is a sequence-specific 
phosphotyrosine-binding structure found in many molecules like JAKs and STATs. This domain 
is responsible for differential interaction of STATs with cytokine receptors in response to 
different stimuli (Hemmann et al., 1996) as well as homo and hetero dimeriziation of activated 
STATs (Gupta et al., 1996, Shuai et al., 1994). And finally the transactivation domain (TAD) is 
located at the C-terminus of the molecule (Muller et al., 1993, Moriggl et al., 1996, Caldenhoven 
et al., 1996, Mui et al., 1996). While tyrosine phosphorylation is obligatory for STAT activation, 
STATs are also phosphorylated on a serine residue located in the TAD domain (Ser
727 
in human 
STAT1), which has to be phosphorylated in order for STAT to exert full activity (Beadling et al., 
1996). Both in STAT1 and STAT2 their TAD domains interact with p300 and CBP (CREB 
binding protein), which both are transcriptional co-activators (Bhattacharya et al., 1996, Zhang et 
al., 1996). 
 
Interferon Regulatory Factor 9 
 
Interferon Regulatory Factors (IRFs) are transcription factors involved in antiviral defense and 
immune response, as well as cell growth regulation and apoptosis. In human, nine members of 
this family are identified (IRF1 – 9) (Paun and Pitha, 2007, Nehyba et al., 2002).  
 
 
DBD IAD N C 
Figure 4: IRF9 structural domains 





All IRFs have a highly conserved DBD in their N-terminal, with a helix – turn – helix formation 
that interacts with DNA through three of its five highly conserved tryptophan (W) residues 
(Escalante et al., 1998) (Figure 4). The C-terminus is more diverse and possesses regulatory 
functions (Barnes et al., 2002, Lin et al., 1999, Lin et al., 2000). Several members of the IRF 
family are involved in IFN signaling in various ways, IRF3, IRF7 and IRF5 are involved in 
expression of type I IFN genes (Juang et al., 1999, Wathelet et al., 1998), while IRF9 is the only 
member of IRF family that is directly involved in the JAK / STAT signaling pathway. In 
response to type I IFN stimulation STAT1, STAT2 and IRF9 interact and form ISGF3 that binds 
to a specific DNA sequence called interferon-stimulated response element (ISRE) (Fu et al., 
1990, Levy et al., 1989). IRF9 in both mouse and human is shown to spontaneously accumulate 
in the nucleus because of a nuclear localization signal (NLS) present within or close to its DBD, 
but it is also detected in the cytoplasm of the cells (Lau et al., 2000).  
 
Regulation of JAK / STAT 
 
In mammals, the JAK/STAT pathway is the principal signaling mechanism for a wide array of 
cytokines and growth factors. Naturally, reduced activity, constitutive activity and / or failure in 
regulation of JAK / STAT signaling may lead to abnormality and disease; this makes its 
regulation essential. There are several molecules and processes involved in down-regulation of 
JAK/STAT signaling activity. Both JAKs and STATs are activated when they are phosphorylated 
on specific tyrosine residues (and serine in some cases) as result of external stimuli (i.e. IFN- 
stimulation), and one efficient strategy to down-regulate their activity is de-phosphorylation of 
these residues. Some of the major phosphatases involved in this process are; SH2-containing 
Protein Tyrosine Phosphatases 1 and 2 (SHP1 and SHP2), CD45, Protein Tyrosine Phosphatase 
1B (PTP1B) and T-cell PTP (TCPTP). 
SHP1 is expressed mainly in hematopoietic cells and is involved in de-phosphorylation of JAK1 
(David et al., 1995) and JAK2 (Klingmuller et al., 1995, Jiao et al., 1996). CD45, a receptor PTP, 
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is a general inhibitor of JAKs and can directly bind to all JAKs and dephosphorylate them (Irie-
Sasaki et al., 2001). PTP1B de-phosphorylates JAK2 and TYK2 (Myers et al., 2001) and TCPTP 
can de-phosphorylate JAK1 and JAK3 (Simoncic et al., 2002). SHP2 interacts with, and de-
phosphorylates STAT5a (Chen et al., 2003, Chughtai et al., 2002) and seems to be involved in 
de-phosphorylation of STAT1. TC45 (the nuclear isoform of TCPTP) and SHP2 de-
phosphorylate STAT1 in the nucleus (ten Hoeve et al., 2002, Wu et al., 2002), a necessary step 
for STAT1 nuclear export. 
Another group of JAK / STAT inhibitors are Protein Inhibitors of STAT signaling (PIAS). 
Members of this group of proteins from drosophila to mammalian species are involved in 
negative regulation of STAT molecules. In mammals this group includes 4 members, PIAS1, 
PIAS3, PIASX and PIASY (Liu et al., 1998, Chung et al., 1997) . PIAS1 and 3 inhibit STAT1 
and 3 respectively (Chung et al., 1997, Liu et al., 1998), by inhibiting their DNA-binding activity. 
PIASX inhibits STAT4 and PIASY interacts with STAT5 and regulates STAT5 mediated gene 
expression. PIASX and PIASY affect STAT4 and STAT1 activity without interfering with their 
DNA-binding activity probably by acting as co-repressors (Arora et al., 2003, Liu et al., 2001). 
A third major group of proteins, and probably most studied group, involved in regulation of JAK 
/ STAT signaling is a number structurally related proteins called Suppressors of Cytokine 
Signaling (SOCS). SOCS molecules are constitutively expressed at low rates, but their expression 
is up-regulated shortly after cytokine stimulation and they are degraded after a short time (Starr et 
al., 1997, Tollet-Egnell et al., 1999, Adams et al., 1998). SOCS proteins inhibit type I and type II 
cytokines using different mechanisms; at the receptor level by competing with the STATs (JAK 
substrates), in binding to the intracellular domains of the activated receptors and on the JAK 
level, by interfering with their kinase activity. They are also involved in ubiquitination and 
proteosomal degradation of JAK and STAT molecules. The SOCS family includes 8 members; 
SOCS 1 – 7 and CIS or CISH (Cytokine-inducible SH2- containing protein) (Hilton, 1999, Hilton 
et al., 1998). They have similar structure which is comprised of a central SH2 domains, which 
like the SH2 domains in STATs has high affinity for phospho-tyrosine residues and defines 
specificity of SOCS, a variable N-terminal, and a 40 aa long sequence known as SOCS box in the 
C-terminal of proteins (Starr et al., 1997) which mediates ubiquitination and proteasomal 
degradation of their target molecules through interaction with the Elongin B and C, known 
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components of the ubiquitin E3 ligase complex. N-terminally to the SOCS1 and SOCS3-SH2 
domain which interacts with tyrosine phosphorylated JAKs and inhibits their function (Endo et 
al., 1997, Starr et al., 1997). SOCS1 and SOCS3 have an additional domain called Kinase 
Inhibitor Region (KIR), a 12 aa long region which interacts with the kinase domain of JAKs and 
strongly inhibits their kinase activity (Yasukawa et al., 1999). SOCS1 and SOCS3 both inhibit 
JAK activity through their SH2 domain (Yasukawa et al., 1999), but while SOCS1-SH2 interacts 
directly with phospho-tyrosine residues of Tyk2 kinase domain to inhibit type I IFN signaling 
(Piganis et al., 2011) , SOCS3 – SH2 interacts with the phosphorylated tyrosine residues on the 
cytokine receptor and its KIR domain interacts with the substrate binding grove of JAK2 and 
blocks substrate association (Kershaw et al., 2013). 
In addition to cytokine stimulation, SOCS are also expressed as a direct result of TLR stimulation 
by viral and bacterial factors like CpG-DNA (Dalpke et al., 2001) and LPS (Nakagawa et al., 
2002). The effect that SOCS exert on cytokine responses in different ways has been used in 
immune evasion strategies of different pathogens (Zimmermann et al., 2006). Different 
pathogenic microorganisms seem to activate expression of SOCS by secreting factors such as 
lipo-proteins (Pai et al., 2003).  
 
 JAK / STAT in fish 
 
Since discovery of IFNs in human in 1957 (Isaacs and Lindenmann, 1957) many different 
members of these family of cytokines have been identified, cloned and characterized both in 
mammalian species and other species of vertebrates like birds (Sekellick et al., 1994), amphibian 
(Grayfer et al., 2014) and fish (references cited below). IFN-like activity in fish was reported 
several decades ago (de Kinkelin and Dorson, 1973), but IFN from fish was cloned and 
characterized for the first time in 2003 in zebrafish (Danio rerio) (Altmann et al., 2003), puffer 
fish (Tetraodontidae) (Lutfalla et al., 2003), and Atlantic salmon (Salmo salar) (Robertsen et al., 
2003) by 3 independent groups. Since then, IFN genes have been identified in several other 
teleost species like channel catfish (Ictalurus punctatus) (Long et al., 2004), common carp 
(Cyprinus carpio L) (Kitao et al., 2009), rainbow trout (Oncorhynchus mykiss) (Chang et al., 
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2009), Rohu (Labeo rohita) (Parhi et al., 2014),  sea bass (Dicentrarchus labrax L.) (Casani et al., 
2009), Fugu (Takifugu rubripes), goldfish (Carassius auratus L) (Grayfer and Belosevic, 2009) 
and Grass carp (Ctenopharyngodon idella) (Li et al., 2012). 
Like mammalian type I IFN, fish IFNs have been shown to possess antiviral activity (Altmann et 
al., 2003, Robertsen et al., 2003) and their expression is upregulated upon viral infections (Collet 
et al., 2007) as well as stimulation with known inducers of mammalian IFNs like poly I : C (a 
synthetic mimic of ds RNA) and CpG DNA (Altmann et al., 2003, Robertsen et al., 2003, 
Pedersen et al., 2006, Chen et al., 2010).  Several studies have established antiviral activity of 
recombinant fish IFNs in different species of teleost (Sun et al., 2011, Chaves-Pozo et al., 2010, 
Chen et al., 2014). Furthermore treatment of fish cells with IFNs are shown to induce of a wide 
range of IFN stimulated genes (ISG), including Mx, viperin, ISG15, PKR, and for some of these 
an enhanced antiviral state in fish cells are found (Chen et al., 2014, Sun et al., 2011, Svingerud 
et al., 2012). 
While members of JAK / STAT signaling pathway have been extensively studied in different 
mammalian species, information about JAK / STAT signaling from fish is still scarce, even 
though molecules involved in this pathway are identified and characterized in several fish 
species. Studies of JAK molecules in round-spotted pufferfish (Leu et al., 1998, Leu et al., 2000) 
and the mandarin fish (Siniperca chuatsi) (Guo et al., 2009) have shown that JAKs in fish harbor 
the same structural composition and are of the same size as their mammalian counterparts. And 
studies in several fish showed that their expression is upregulated as a result of stimulation with 
IFNs and other IFN-signaling activators like CpG and poly I:C (Guo et al., 2009, Leu et al., 1998, 
Leu et al., 2000).  
STAT1 and STAT2 have also been studied in different piscine species including Olive flounder 
(Paralichthys olivaceus) (Park et al., 2008) , pufferfish and in zebrafish (Stein et al., 2007), the 
mandarin fish (Siniperca chuatsi) (Guo et al., 2009), Atlantic salmon (Collet et al., 2008, Collet 
et al., 2009, Skjesol et al., 2010), crucian carp (Carassius auratus L.) (Zhang and Gui, 2004, Yu 
et al., 2010), turbot (Scophthalmus maximus) (Wang et al., 2013) and it has been shown that their 
expression is upregulated as result of CpG, poly I : C and IFN stimulation. The fact that Atlantic 
salmon STAT1 is the target of immune evasion for some viruses like IPNV and ISAV (Collet et 
al., 2008) and turbot STAT2 expression is upregulated in response to virus infection (Wang et al., 
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2013), provide further evidence of involvement of  teleost JAK/STAT in the organisms immune 
response to viral infection. 
IRF9 from a few fish species have been identified (Shi et al., 2013, Shi et al., 2012). IRF9 
homologue from crucian carp was shown to translocate spontaneously to the nucleus, while it 
was still detectable to some degree in the cytoplasm (Shi et al., 2012). IRF9 has both ISRE and 
GAS elements in its promoter region but in zebrafish its expression was primarily upregulated as 
a result of IFNγ stimulation. Transfection of carp epithelioma papulosum cyprini (EPC) cells 
with IRF3 and IRF7 as well as combination of IRF9 and STAT2, lead to activity of IRF9 
promoter in luciferase assay (Shi et al., 2013). 
 
Studies of SOCS in fish 
 
In addition to ortologs to all SOCS found in mammals (SOCS1 – 7 and CISH) also several novel 
members of this family (SOCS-3b, SOCS-5b, SOCS-8 and SOCS-9) are found in teleost fish (Jin 
et al., 2008).  Like SOCS from mammalian species, SOCS molecules from pufferfish, zebrafish, 
fugu,, japanese rice fish (Oryzias latipes) (Jin et al., 2007a, Jin et al., 2007b) and common carp 
(Xiao et al., 2010) possess similar domain like structures and have been expressed in all of the 
examined tissues.  
The induction of fish SOCS gene expression is SOCS member-, cell type and cytokine 
dependent. Furthermore, like their mammalian counterparts, the fish SOCS are also induced by 
PAMPS and bacterial, viral and parasitic infections (Wang et al., 2011). For example in 
pufferfish, zebrafish, fugu, three-spined stickleback (Gasterosteus aculeatus) and the Japanese 
rice fish expression of SOCS 1 – 5, SOCS9 as well as CISH was upregulated as a result of LPS 
stimulation (Jin et al., 2007a). SOCS1 from both zebrafish and pufferfish were induced by IFN 
stimulation and its overexpression did inhibit expression of ISGs like Mx and Viperin (Nie et al., 
2014). In fact SOCS1 is one of the main regulators of type I and II IFN signaling in mammals 
(Qing et al., 2005) as well as fish (Nie et al., 2014) and this also have been documented by our 
group (Skjesol et al., 2014). In rainbow trout stimulation with IFNγ, poly I:C and LPS lead to 
upregulation of SOCS1 – 3, but not of SOCS6, 7 and 9 (Wang et al., 2010, Wang and Secombes, 
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2008). Expression of Carp SOCS3 has been shown to be upregulated as result of virus infection 
(Xiao et al., 2010). Turbot SOCS3 homologue (named SmSOCS3) expression was upregulated as 
a result of bacterial infection as well as TNF stimulation and SmSOCS3 overexpression in HK 
macrophages inhibited the transcription of TNF-α as well as IL-1β and CC-chemokine (Zhang et 
al., 2011). These studies show that like their mammalian counterparts, SOCS molecules in bony 
fish are involved in regulation of inflammatory responses. 
 
Aims of study 
 
One of the main defense mechanisms activated in vertebrates in response to viral infection is the 
IFN activated JAK/STAT signaling pathway. On the other hand, in the course of their evolution 
viruses have developed strategies to counter this mechanism in order to infect the host organism. 
These strategies usually involve virus proteins disturbing different immune responses by 
attacking specific molecules involved in the immune response. A better understanding of 
molecules that are targeted and the processes that are inhibited by viruses is a necessity in order 
to design efficient vaccines against those viruses. 
The aim of this study was to enhance understanding of JAK/STAT signaling in Atlantic salmon. 
To do so, major molecules involved in this pathway were cloned and/or characterized. The 
molecules cloned and characterized are: 
- Tyk2 
- STAT1a (characterization) 
- STAT2 a/b 
- IRF9 
- SOCS1 






Summary of papers 
 
Paper I 
Mehrdad Sobhkhez, Tom Hansen, Dimitar B. Iliev, Astrid Skjesol, Jorunn B. Jørgensen 
The Atlantic salmon protein tyrosine kinase Tyk2: molecular cloning, modulation of 
expression and function. Dev Comp Immunol. 41(4): 553 – 63. 
Tyk2, a member of the Janus Kinase (JAK) family of protein tyrosine kinases, is required for 
interferon-α/β binding and signaling in higher vertebrates. Currently, little is known about the 
role of the different JAKs in signaling responses to interferon (IFN) in lower vertebrates 
including fish. In this paper we report the identification and characterization of Atlantic salmon 
(Salmo salar) Tyk2. Four cDNA sequences, two containing an open reading frame encoding full-
length Tyk protein and two with an up-stream in frame stop codon, were identified. The deduced 
amino acid sequences of the salmon full-length Tyk2 proteins showed highest identity with Tyk2 
from other species and their transcripts were ubiquitously expressed. Like in mammals the 
presented data suggests that salmon Tyk2 is auto-phosporylated when ectopically expressed in 
cells. In our experiments, full-length salmon Tyk2 overexpressed in CHSE-cells phosphorylated 
itself, while both a kinase-deficient mutant and the truncated Tyk2 (Tyk-short) were inactive. 
Interestingly, the overexpression of full length Tyk2 was shown to up-regulate the transcript 
levels of the IFN induced gene Mx, thus indicating the involvement of salmon Tyk2 in the 
salmon IFN I pathway. 
 
Paper II 
Sobhkhez, M., Skjesol, A., Thomassen E., Greiner–Tollersrud L., Iliev, D.B.,  Sun, B., Robertsen 
B. & J. B. Jørgensen (2014)  
Structural and functional characterization of salmon STAT1, STAT2 and IRF9 homologs 
sheds light on IFN signaling in teleosts. Manuscript. 
Mammalian IRF9 and STAT2, together with STAT1, form the IFN-stimulated gene factor 3 
transcription factor (ISGF3) complex, which is critical for type I IFN induced signaling, while 
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most JAK and STAT family members, however, description of their functional activity in lower 
vertebrates is still scarce. In the present study we have identified two different STAT2 homologs 
and one IRF9 homolog from Atlantic salmon (Salmo salar L). Both proteins  have domain-like 
structures with functional motifs that are similar to higher vertebrates suggesting that they are 
orthologs to mammalian STAT2 and IRF9. The two identified salmon STAT2, named STAT2a 
and STAT2b, showed high sequence identity but were divergent in their transactivation domain 
(TAD). Like STAT1, ectopically expressed STAT2a and b were shown to be tyrosine 
demonstrated that both STAT2a and STAT2b co-localized with STAT1a in the cytoplasm of 
med to favor their nuclear localization. 
Overexpression of STAT2a or STAT2b together with STAT1a activated a GAS-containing 
reporter gene construct in IFNγ stimulated cells. Of notice, the highest induction of GAS 
promoter activation was found in IFNγ stimulated cells transfected with IRF9 alone. Taken 
signaling and promote the expression of GAS-driven genes in bony fish.   
 
Paper III 
Astrid Skjesol, Theresa Liebe, Dimitar B. Iliev, Ernst I Thomassen, Linn G. Tollersrud, Mehrdad 
Sobhkhez, Lisbeth Lindenskov Joensen, Chris J. Secombes and Jorunn B. Jørgensen 
Functional conservation of suppressors of cytokine signaling proteins between teleosts and 
mammals: Atlantic salmon SOCS1 binds to JAK/STAT family members and suppresses 
type I and II IFN signaling. Dev Comp Immunol 45(1): 177 – 89.  
Suppressor of cytokine signaling (SOCS) proteins are crucially involved in the control of 
inflammatory responses through their impact on various signaling pathways including the 
JAK/STAT pathway. Although all SOCS protein family members are identified in teleost fish, 
their functional properties in non-mammalian vertebrates have not been extensively studied. To 
gain further insight into SOCS functions in bony fish, we have identified and characterized the 
Atlantic salmon (Salmo salar) SOCS1, SOCS2 and CISH genes. These genes exhibited sequence 
conservation with their mammalian counterparts and they were ubiquitously expressed. SOCS1 
in mammalian species has been recognized as a key negative regulator of interferon (IFN) 
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signaling and recent data for the two model fish Tetraodon (Tetraodon nigroviridis) and zebrafish 
(Danio rerio) suggest that these functions are conserved from teleost to mammals. In agreement 
with this we here demonstrate a strong negative regulatory activity of salmon SOCS1 on type I 
and type II IFN signaling, while SOCS2a and b and CISH only moderately affected IFN 
responses. SOCS1 also inhibited IFNγ-induced nuclear localization of STAT1 and a direct 
interaction between SOCS1 and STAT1 and between SOCS1 and the Tyk2 kinase was found. 
Using SOCS1 mutants lacking either the KIR domain or the ESS, SH2 and SOCS box domains 
showed that all domains affected the ability of SOCS1 to inhibit IFN-mediated signaling. These 
results are the first to demonstrate that SOCS1 is a potent inhibitor of IFN-mediated JAK-STAT 

















Discussion of the main findings. 
 
All our findings have been thoroughly discussed in attached papers (papers: I, II and III). The 
following section will focus on parts of the finding and will complement the discussions in the 




Tyk2 and JAK1 associate with intracellular domain of type I IFN receptor while JAK1 and JAK2 
with that of type II IFN. Since Tyk2 is the kinase specifically involved with type I IFN signaling 
and many viruses inhibit JAK / STAT signaling as part of their strategy to evade antiviral 
immunity, we decided to clone and characterize Tyk2 from Atlantic salmon. This was motivated 
by earlier data published by our group where we could demonstrate that IPNV is able to 
antagonize type I IFN-signaling in different salmonid cell-lines (Skjesol et al., 2009) and by 
unpublished data suggesting that the virus target proteins at or upstream of STAT1 
phosphorylation (A. Skjesol and T. Hansen, unpublished data).   
Our efforts lead to identification of four different isoforms of salmon Tyk2, ssTyk2-1 to 4, two of 
which (1 and 4) encode full length molecules with a conserved structure among vertebrate JAKs 
containing a C -terminal: kinase, followed by a pseudokinase, and then a SH2-homology and a 
FERM domain. Tyk2-2 and Tyk2-3 were shorter molecules and their sequences included only the 
FERM domain and part of the SH2 domain. Moreover, phylogenetic analysis indicated that 
salmon Tyk2s are true orthologs of the mammalian Tyk2. Reports from other organisms have 
shown that different factors involved in JAK/STAT signaling are expressed in all tissues that 
were studied (Yang et al., 1993, Stark and Darnell, 2012, Shuai and Liu, 2003). This was also the 
case here; Tyk2 was expressed in all organs from healthy salmon with some variations in the 
expression level. In addition, studies of the primary leucocytes from head kidney and spleen as 
well as CHSE-214 and TO cell lines showed evidence of upregulated Tyk2 mRNA upon both 
type I and II IFN stimulation.  
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When JAKs are brought in the proximity of each other they are activated through 
phosphorylation of tyrosine residues located in their kinase domain. Our studies showed that 
overexpressed Tyk2 is spontaneously tyrosine phosphorylated, and this phosphorylation occurs 
on the tyrosine residues located in the kinase domain. This became evident when we expressed 
and studied different domains of Tyk2 separately. We didn't observe any phosphorylation of 
tyrosine residues in the point mutated Tyk2 (Tyk2 K917R) even though tyrosine residues which 
are phosphorylation targets were intact. This led us to conclude that the phosphorylation observed 
was due to auto-activity and not caused by the activity of another kinase. 
Tyk2 is described as an important component for an efficient induction of ISGs. Our studies 
showed that auto-phosphorylated Tyk2 was able to increase Mx-promoter activity in CHSE cells 
using a luciferase reporter construct, something that neither Tyk2-short (Tyk2-3) nor the Tyk2 
K917R mutant were able to do. Furthermore,  overexpressing Tyk2 in CHSE cells lead to 
upregulated Mx transcript levels, something that was not detected in control cells (cells only 
transfected with GFP-empty vector  or Tyk2 K917R). These data provided strong indication of 
Tyk2 being activated when it is in proximity of other Tyk2 molecules; this activity is due to 
tyrosine phosphorylation of the kinase domain and Tyk2 activation leads to expression of ISGs 
like Mx. 
 
STAT1 & 2 
 
Activation of JAKs as result of type I IFN stimulation leads to phosphorylation and hetero 
dimerization of STAT1 and  2 and their association with IRF9. These three factors together 
constitute Interferon Stimulated Gene Factor 3 (ISGF3). Formation and translocation ISGF3 to 
the nucleus and its binding to specific DNA sequences lead to expression of many ISGs.  
Earlier studies from our research group had already stated  that salmon STAT1a was tyrosine 
phosphorylated upon IFNa1 and IFNγ stimulation(Skjesol et al., 2010). Our attempts to further 
characterize the molecule lead to identification of the tyrosine target for phosphorylation as result 
of IFN stimulation. We showed that this tyrosine (tyrosine 695) is located in the SH2 domain. 
Interestingly, no phosphorylated tyrosine residues were detected when the SH2 domain itself was 
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ectopically expressed, something that indicated requirement of the whole STAT1a sequence for 
tyrosine phosphorylation. Further studies showed that STAT1a is tyrosine phosphorylated when 
cells are stimulated with IFNa1, IFNc and IFNγ and that it translocated to the nucleus when cells 
transiently transfected with STAT1a were stimulated with IFNa1 and IFNγ. 
Our search for salmon STAT2 resulted in identification and characterization of two isoforms - 
STAT2a and STAT2b. In addition, there is a previously identified STAT2 homolog (Collet et al., 
2009) which we named STAT2c. As expected, all STAT2 isoforms displayed conserved 
structural domains, like other STAT molecules.  All three isoforms had high aa identity with each 
other and their aa sequences were identical in N-terminus, STAT2a and b were also identical in 
coiled – coil domain and different from STAT2c, while STAT2a and c were identical in TAD 
domain which was different from STAT2b TAD. Since it has been reported that the coiled-coil 
domain is involved in protein interactions and that the TAD domain does interact with 
transcription co-activators, it seems that these different sequences are involved in recruiting 
different molecules and could be involved in different activities of STAT2 in salmon.  
While as previously shown STAT1a did translocate to the nucleus as result of IFN stimulation 
(Skjesol et al., 2010), when STAT2a/b were expressed alone they did not translocate. However, 
they did translocate to the nucleus in response to IFN stimulation when they were co-expressed 
with STAT1a. This was an interesting observation that needs to be explained. One possible 
explanation would lie on the availability of endogenous STAT1. If STAT1a is available in lower 
concentration then it could mean that there was need for STAT1a over-expression in order for 
STAT2 to translocate. We know that STAT1a protein expression is upregulated when cells are 
stimulated with IFN. But in general it seems that STAT2 needs hetero dimerization in order to 
translocate to the nucleus, this leaves a lingering question that needs to be answered; does salmon 




Last major molecule involved in ISG3 formation is IRF9. Study of the salmon IRF9 sequence 
revealed that this molecule had the classic IRF molecule structure, with a DBD which included 
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five conserved tryptophan (W) residues in exactly the same position as in mammalian IRF9. At 
the end of the DBD there is one segment of aa identified by online NLS finding software 
(http://nls-mapper.iab.keio.ac.jp/cgi-bin/NLS_Mapper_form.cgi) as a possible NLS. Also, an 
IAD domain is located at the C-terminus of the molecule. This domain showed high divergence 
compared to IRF9 sequences from other species.  
Since direct interaction between Tyk2 and STAT molecules as well as interaction between 
STAT1, STAT2 and IRF9 is essential in formation of ISGF3 and ISG expression in mammals, 
we wanted to find out whether these interactions exist in salmon. Our co-IP and confocal 
microscopy data showed that these molecules did indeed interact and co-localized with each 
other.  
We found out that overexpressed salmon IRF9 spontaneously accumulated in the nucleus and in 
reporter gene assay it activated a GAS element when stimulated with IFNγ. In addition, STAT2a 
and b alone also activated the GAS element upon IFNγ stimulation, while, STAT1a did not do 
that. This could be due to the experimental limitation. For these experiments we used CHSE-214 
cell-lines and the transient transfections showed varying efficiency which might have influenced 
the results. To be able to discuss the role that IRF9 plays in GAS activity in salmon compared to 
higher vertebrates, one has to perform similar experiments in a mammalian setup , only then it’s 
possible to discuss these finding in comparison with the role that IRF9 plays in higher vertebrates 





Activated JAK STAT signaling is necessary for anti-viral activity of the cells. Lack of regulation 
or spontaneous activity of the signaling can cause many unwanted affects like auto-immunity. 
That's why JAK STAT activity is tightly regulated. SOCS molecules are one of the most 
important regulatory molecules. 
To shed light on the regulation of Atlantic salmon JAK/STAT signaling three members of this 
family were cloned: SOCS1, SOCS2 (two isoforms: a and b) and CISH. The structural 
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arrangements for all three SOSC-family members identified here were similar to the mammalian 
SOCS proteins as discussed in paper III. We studied possible inhibitory effect of SOCS proteins 
on different IFN induced promoters using reporter gene assay. While our data showed moderate 
negative regulatory effect of SOCS2a, SOCS2b and CISH on both IFNa1 and IFNγ signaling, 
SOCS1 managed to completely abolish effect of both IFNa1 and IFNγ on the promoter activity. 
Like Tyk2, STAT1, STAT2 and IRF9, also SOCS molecules are expressed in all tissues of 
healthy salmon that were included in the study and their expression was regulated (up-regulated) 
by IFN stimulation as well as the IFN inducing immunostimulants CpG and poly I:C. Our results 
showed that while different domains of the molecules have variable impact on the regulation of 
JAK / STAT signaling, the full-length molecules are required for full function. SOCS1 like its 
mammalian counterpart did translocate to the nucleus and co-expression of SOCS1 with STAT1 




While we tried to expand this study as much as possible – given the time we had – to answer 
main questions related to Atlantic salmon Tyk2, STAT1, STAT2 and IRF9 and their role in IFN-
signaling in bony fish, there are many questions that remain to be answered. 
The fact that STAT2a, b, and c have different aa-sequences in essential domains (coiled-coil and 
TAD) speaks of their possibility to interact with different cellular regulators and co-activators. 
Identification of those molecules could provide us with information about possible novel roles 
JAK/STAT signaling may have in bony fish for example shed light on the possible role STAT2a 
and STAT2b play in activation of GAS element. 
We identified putative NLS sequences in STAT1, STAT2a, STAT2b and IRF9 by aa-identity to 
already characterized NLS from mammalian molecules. It remains to be proven if these 
sequences do have the expected function in salmon or not. This is especially important for the 
STAT2 isoforms. The fact that STAT2 is only translocated to the nucleus when it is co-expressed 
with STAT1a or IRF9, questions the presence of a functional NLS sequence in salmon STAT2. 
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And finally the most interesting finding in this study is the stimulatory role that IRF9 may have 
for GAS element. To our knowledge earlier findings have only documented that IRF9 and 
unphosphorylated STAT2 are implicated in IFNγ signaling through the formation of ISGF
II
 and 
ISRE activation (Morrow et al., 2011). Our findings indicate that they may have a stimulatory 
role on GAS element. This certainly needs further elucidation. One way to do so is to introduce 
point mutations on the tryptophan residues in DBD that are essential for IRF9 function. 
Elimination or reduction of GAS activity in cells transfected with mutant IRF9 upon stimulation 
with IFNγ could be done to elucidate weather IRF9 has a role in the activation of GAS element. 
Of course here it’s important to consider the shortcomings of the methods used. While reporter 
gene assay is broadly used, it has its shortcomings. The result could be affected by the cell-type, 
transfection efficiency, endogenous molecules present and the fact that this method excludes the 


















- Tyk2, STAT2 (two isoforms), IRF9, SOCS1, SOCS2 (two isoforms) and CHISH from 
Atlantic salmon have been cloned. 
- Overexpressed Tyk2 is auto-activated as result of tyrosine phosphorylation and this leads 
to expression of ISGs in CHSE-214 cells. 
- STAT1a and STAT2 a/b are phosphorylated as result of  type I and II IFN stimulation. 
- Tyk2, STAT1a, STAT2a/b and IRF9 interact with each other. 
- IRF9 spontaneously accumulates in the nucleus when overexpressed. 
- STAT2a/b translocate to the nucleus when co-expressed with STAT1a as result of both 
type I and type II IFN stimulation  
- STAT2a/b translocate to the nucleus when co-expressed with the IRF9. 
- IRF9 seems to activate GAS element in CHSE-214 cells. 
- Expressions of all these molecules are up-regulated as result of IFN stimulation, this 
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